The National MS Society funds research projects worldwide with three goals in mind: stopping MS, restoring function, and ending MS forever. The Society is currently funding these projects in the Oregon Chapter.
Collaborative MS Research Center Award
Understanding MS damage that leads to progressive disability.
Dennis Bourdette, M.D.
Oregon Health & Science University - Portland, Oregon
Funding: $767,250 Term: 4/1/2008-3/31/2013
Effects of inflammatory mediators on axonal transport in cultured neurons and in intact optic nerves
Exploring whether faulty transfer of proteins inside nerve cells contributes to their damage in MS.
Cheng Fang, Ph.D.
Oregon Health & Science University - Portland, Oregon
Funding: $156,515 Term: 7/1/2010-6/30/2013
Rehabilitation research training in postural control of multiple sclerosis
Developing a training program to enhance research into ways to use rehabilitation to improve balance and gait in people with MS.
Fay Horak, Ph.D., P.T.
Oregon Health & Science University - Beaverton, Oregon
Funding: $407,466 Term: 7/1/2009-6/30/2014
Immunoregulatory effects of estrogen in EAE
Investigating how sex hormones like estrogen combat an MS model in order to enhance their potential effectiveness as therapies for MS.
Halina Offner, Ph.D.
Oregon Health & Science University - Portland, Oregon
Funding: $472,981 Term: 11/1/2009-10/31/2012
Immunoregulation and neuroprotection by RTLs in EAE
Developing a possible therapy to stop the immune attack in MS.
Halina Offner, Ph.D.
Oregon Health & Science University - Portland, Oregon
Funding: $505,494 Term: 10/1/2009-9/30/2012
Effects of RTL therapy on encephalitogenic T cells and CNS parenchyma in EAE
Defining changes that may occur in the immune response as a result of a novel therapy now undergoing early testing in MS.
Sushmita Sinha, Ph.D.
Oregon Health & Science University - Portland, Oregon
Funding: $150,800 Term: 7/1/2008-6/30/2011
Validation of an instrumented gait measure, the immobility, in MS
Evaluating the sensitivity and quality of an electronic instrument to detect gait abnormalities and to measure changes in mobility over time.
Rebecca Spain, M.D., M.S.P.H.
Oregon Health & Science University - Portland, Oregon
Funding: $44,000 Term: 12/1/2010-11/30/2011
Lipoic acid as a treatment for acute optic neuritis: a pilot trial
A clinical trial to determine whether an oral antioxidant can prevent nerve damage in people with optic neuritis, often the first symptom of MS.
Vijayshree Yadav, M.D.
Oregon Health & Science University - Portland, Oregon
Funding: $491,950 Term: 4/1/2011-3/31/2014